HER-2-Negative Breast Cancer Limitations and Next-Generation Sequencing Technology Promises

被引:1
|
作者
Baltogiannis, Georgios [1 ]
Katsios, Christos [1 ]
Zografos, George C. [2 ]
Roukos, Dimitrios H. [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Surg, GR-45110 Ioannina, Greece
[2] Univ Athens, Dept Surg 1, Athens, Greece
关键词
Epidermal Growth Factor Receptor; Trastuzumab; CXCR4 Expression; Comparative Effectiveness Research; Epidermal Growth Factor Receptor Family;
D O I
10.1245/s10434-010-0973-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1720 / 1720
页数:1
相关论文
共 50 条
  • [41] Next-Generation Sequencing for HER2 Status in Breast Cancer: Comparison with Immunohistochemistry and in situ Hybridization by 2018 Focused Update
    Mooney, Kelly
    Stehr, Henning
    Kunder, Christian
    Zehnder, James
    Allison, Kimberly
    Lin, Chieh-Yu
    LABORATORY INVESTIGATION, 2019, 99
  • [42] Ten years of next-generation sequencing technology
    van Dijk, Erwin L.
    Auger, Helene
    Jaszczyszyn, Yan
    Thermes, Claude
    TRENDS IN GENETICS, 2014, 30 (09) : 418 - 426
  • [43] The impact of next-generation sequencing technology on genetics
    Mardis, Elaine R.
    TRENDS IN GENETICS, 2008, 24 (03) : 133 - 141
  • [44] Next-generation sequencing technology: a boon to agriculture
    Balakrishnan Marudamuthu
    Tamanna Sharma
    Supriya Purru
    S. K. Soam
    Ch. Srinivasa Rao
    Genetic Resources and Crop Evolution, 2023, 70 : 353 - 372
  • [45] Next-generation sequencing technology in clinical virology
    Capobianchi, M. R.
    Giombini, E.
    Rozera, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (01) : 15 - 22
  • [46] Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
    Weisman, Paul S.
    Ng, Charlotte Ky
    Brogi, Edi
    Eisenberg, Rachel E.
    Won, Helen H.
    Piscuoglio, Salvatore
    De Filippo, Maria R.
    Ioris, Rafael
    Akram, Muzaffar
    Norton, Larry
    Weigelt, Britta
    Berger, Michael F.
    Reis-Filho, Jorge S.
    Wen, Hannah Y.
    MODERN PATHOLOGY, 2016, 29 (05) : 476 - 488
  • [47] Next-Generation Sequencing for HER2 Status in Breast Cancer: Comparison with Immunohistochemistry and in situ Hybridization by 2018 Focused Update
    Mooney, Kelly
    Stehr, Henning
    Kunder, Christian
    Zehnder, James
    Allison, Kimberly
    Lin, Chieh-Yu
    MODERN PATHOLOGY, 2019, 32
  • [48] Clinical Integration of Next-Generation Sequencing Technology
    Gullapalli, R. R.
    Lyons-Weiler, M.
    Petrosko, P.
    Dhir, R.
    Becich, M. J.
    LaFramboise, W. A.
    CLINICS IN LABORATORY MEDICINE, 2012, 32 (04) : 585 - +
  • [49] Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel
    Ben-Baruch, Noa
    Peretz-Yablonski, Tamar
    Fried, Georgeta
    Inbar, Moshe J.
    Samih, Yousef
    Neiman, Victoria
    Nisenbaum, Bella
    Drumea, Karen
    Friedman, Neil
    Weitzen, Rony
    Safra, Tamar
    Soussan-Gutman, Lior
    Dvir, Addie
    Stephens, Phil
    Wang, Kai
    Miller, Vincent A.
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC)
    Lips, Esther H.
    Michaut, Magali
    Mulder, Lennart
    Besselink, Nicolle
    Hoogstraat, Marlous L.
    Koudijs, Marco J.
    Voest, Emile E.
    Bernards, Rene
    Wesseling, Jelle
    Wessels, Lodewyk F. A.
    Rodenhuis, Sjoerd
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)